Atlas Trials

Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia Patients

Clinical trial NCT02936414 · COMPLETED

Trial details

NCT number
NCT02936414
Sponsor
Tianjin Anding Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Schizophrenia
Start date
2014-07-01
Primary completion
2015-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.